Topotecan-Vincristine-Doxorubicin in Stage 4 High-Risk Neuroblastoma Patients Failing to Achieve a Complete Metastatic Response to Rapid COJEC: A SIOPEN Study
Loredana Amoroso, Giovanni Erminio, Guy Makin, Andrew D. J. Pearson, Penelope Brock, Dominique Valteau-Couanet, Victoria Castel, Marlène Pasquet, Genevieve Laureys, Caroline Thomas, Roberto Luksch, Ruth Ladenstein, Riccardo Haupt, Alberto Garaventa,
Cancer Res Treat. 2018;50(1):148-155.   Published online 2017 Mar 21     DOI:
Citations to this article as recorded by Crossref logo
Molecular mechanisms and therapeutic targets in neuroblastoma
John Inge Johnsen, Cecilia Dyberg, Susanne Fransson, Malin Wickström
Pharmacological Research.2018; 131: 164.     CrossRef
Updated clinical and biological information from the two-stage phase II study of imatinib mesylate in subjects with relapsed/refractory neuroblastoma
F Morandi, L Amoroso, A Dondero, R Castriconi, S Parodi, R Luksch, F Casale, A Castellano, A Garaventa, A Moretta, C Bottino, M Ponzoni, MV Corrias
OncoImmunology.2018;[Epub]     CrossRef
Investigational drugs in phase II clinical trials for the treatment of neuroblastoma
Loredana Amoroso, Riccardo Haupt, Alberto Garaventa, Mirco Ponzoni
Expert Opinion on Investigational Drugs.2017; 26(11): 1281.     CrossRef